Schrag, Anette

Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results

Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez‐Martin, P., Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., et al. (2008) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 7,536

Parkinson disease

Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 5,415

Prediagnostic presentations of Parkinson’s disease in primary care: A case-control study

Schrag, A., Horsfall, L., Walters, K., Noyce, A., & Petersen, I. (2015) · The Lancet Neurology

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 674

Visual dysfunction in Parkinson’s disease

Weil, R. S., Schrag, A. E., Warren, J. D., Crutch, S. J., Lees, A. J., & Morris, H. R. (2016) · Brain

Parkinson's Disease Mechanisms and TreatmentsVisual perception and processing mechanisms

Cited by 481

The EQ-5D---a generic quality of life measure---is a useful instrument to measure quality of life in patients with Parkinson's disease

Schrag, A. (2000) · Journal of Neurology, Neurosurgery & Psychiatry

Health Systems, Economic Evaluations, Quality of LifeParkinson's Disease Mechanisms and Treatments

Cited by 327

What contributes to depression in Parkinson's disease?

SCHRAG, A., JAHANSHAHI, M., & QUINN, N. P. (2001) · Psychological Medicine

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 242

Constipation preceding Parkinson's disease: a systematic review and meta-analysis

Adams-Carr, K. L., Bestwick, J. P., Shribman, S., Lees, A., Schrag, A., & Noyce, A. J. (2016) · Journal of Neurology, Neurosurgery & Psychiatry

Parkinson's Disease Mechanisms and TreatmentsGastrointestinal motility and disorders

Cited by 228

Psychosis, apathy, depression and anxiety in Parkinson's disease

Gallagher, D. A., & Schrag, A. (2012) · Neurobiology of Disease

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 211

Psychiatric aspects of Parkinson?s disease: An Update

Schrag, A. (2004) · Journal of Neurology

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 200

Whole genome sequencing for the diagnosis of neurological repeat expansion disorders in the UK: a retrospective diagnostic accuracy and prospective clinical validation study

Ibañez, K., Polke, J., Hagelstrom, R. T., Dolzhenko, E., Pasko, D., Thomas, E. R. A., Daugherty, L. C., Kasperaviciute, D., Smith, K. R., McDonagh, E. M., et al. (2022) · The Lancet Neurology

Genetic Neurodegenerative DiseasesGenomics and Rare Diseases

Cited by 187

A questionnaire-based (UM-PDHQ) study of hallucinations in Parkinson's disease

Papapetropoulos, S., Katzen, H., Schrag, A., Singer, C., Scanlon, B. K., Nation, D., Guevara, A., & Levin, B. (2008) · BMC Neurology

Hallucinations in medical conditionsParkinson's Disease Mechanisms and Treatments

Cited by 111

Lower Lymphocyte Count is Associated With Increased Risk of Parkinson's Disease

Jensen, M. P., Jacobs, B. M., Dobson, R., Bandres‐Ciga, S., Blauwendraat, C., Schrag, A., Noyce, A. J., & The International Parkinson's Disease Genomics Consortium (IPDGC) (2021) · Annals of Neurology

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 91

The experience of Anxiety for people with Parkinson’s disease

Blundell, E. K., Grover, L. E., Stott, J., & Schrag, A. (2023) · npj Parkinson's Disease

Parkinson's Disease Mechanisms and TreatmentsAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 41

The Role of Cognitive-Behavioural Therapy for Patients with Depression in Parkinson's Disease

Charidimou, A., Seamons, J., Selai, C., & Schrag, A. (2011) · Parkinson's Disease

Parkinson's Disease Mechanisms and TreatmentsAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 22

Are patients with somatization disorder highly suggestible

Brown, R. J., Schrag, A., Krishnamoorthy, E., & Trimble, M. R. (2008) · Acta Psychiatrica Scandinavica

Psychosomatic Disorders and Their TreatmentsPain Management and Placebo Effect

Cited by 11